Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage.

European journal of clinical pharmacology - 1 Jan 2000

Raslová K, Dobiásová M, Nagyová A, Fábry R, Rauchová H, Dusinská M

Abstract excerpt

OBJECTIVES: This study was conducted to examine a complex effect of ciprofibrate therapy in patients with atherogenic lipoprotein phenotype. METHODS: Effects of ciprofibrate were studied on HDL subpopulations, HDL ability to esterify cholesterol (FER(HDL)), susceptibility of LDL to oxidation as w...

Topics

Arteriosclerosis
Clofibric Acid
DNA Damage
Female
Fibric Acids
Humans
Hypolipidemic Agents
Kinetics
Lipoproteins
Lipoproteins, HDL
Lipoproteins, LDL
Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Male

Middle Aged

Oxidation-Reduction

Phenotype

Source

Identifiers

PMID: 9923570
DOI: 10.1007/s002280050537

Genes

FER

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9923570-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage.PMID 9923570Read ↗

Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.Semantic proximity Read ↗

Overview of fenofibrate.Semantic proximity Read ↗

The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.Semantic proximity Read ↗

Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency.Semantic proximity Read ↗

Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.Semantic proximity Read ↗

A beneficial effect of simvastatin on DNA damage in 242T allele of the NADPH oxidase p22phox in hypercholesterolemic patients.Semantic proximity Read ↗

Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants.Semantic proximity Read ↗

A new mathematical model to quantify and characterize the response to pro- and anti-oxidants of the copper-induced oxidation of LDL assay. A tool for examination of potential preventive compounds and clinical risk predictionSemantic proximity Read ↗

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.Semantic proximity Read ↗

Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients.Semantic proximity Read ↗

The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.